Boehringer bets $2B in biobucks to unlock siRNA targets for MASH treatments
Get ready for the Roche (Remix), ft. a $30M small molecule deal
CG Oncology plans IPO plunge ahead of phase 3 bladder cancer drug readout
Sciwind blows into GLP-1 contention with pivotal data on Chinese rival to Novo, Lilly
‘An attractive opportunity for investing’: Goldman Sachs closes $650M fund aimed at biotechs
Anavex stock sinks 30% as lead asset fails to improve Rett syndrome in children
Roche designs new antibiotic to fight deadly A. baumannii infections